TRAIL suppresses gut inflammation and inhibits colitogeic Tcell activation in experimental colitis via an apoptosisindependent pathway

TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway

11:28 EDT 11 May 2019 | Nature Publishing

More From BioPortfolio on "TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway"